Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 18, 2026
Approximately 5 minutes
TGA Annual Reporting Obligations for High-Risk Medical Devices
TGA Annual Reporting Obligations for High-Risk Medical Devices
1. Overview and Purpose
The Therapeutic Goods Administration (TGA) requires sponsors of certain high-risk medical devices to submit annual reports for the first three years following inclusion in the Australian Register of Therapeutic Goods (ARTG). This requirement, under Regulation 5.11 of the Therapeutic Goods (Medical Devices) Regulations 2002, aims to confirm that devices continue to meet the Essential Principles for safety and performance, and that post-market surveillance can identify issues early. Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
Reports cover data from both Australia and worldwide.
2. Devices Requiring Annual Reports
Annual reporting applies to:
- Implantable Class IIb devices
- Class III devices
- Active Implantable Medical Devices (AIMD), now classified as Class III
This focuses on high-risk devices new to the Australian market. Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
3. Reporting Period and Deadlines
Reports cover the period from 1 July to 30 June and are due by 1 October each year. Key timing details:
- First report: Covers at least six months but no longer than 18 months after ARTG inclusion
- Subsequent reports: Submitted by 1 October for the next two years (total of three reports)
- If inclusion is between 1 July and 31 December, first report due the following 1 October
- If inclusion is between 1 January and 30 June, first report due the following 1 October
The TGA does not send reminders; failure to submit may lead to ARTG revocation. Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
4. Required Information in Reports
Reports must be presented by product/model in a clear table format and include:
- ARTG number
- Product name(s)
- Model number(s)
- Number of devices supplied in Australia and worldwide
- Number of complaints in Australia and worldwide
- Number of adverse events and incident rates (Australia and worldwide)
- List of all complaints and adverse events with jurisdiction
- TGA Device Incident Report (DIR) numbers
- Details of regulatory/corrective actions or notifications
A template is available for structuring reports. Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
5. Submission Process
Submit reports electronically via email to medicaldevicesurveillance@health.gov.au, addressed to the Annual Report Coordinator. Reports are treated as confidential and used for ongoing monitoring. The TGA reviews submissions and contacts sponsors only if further information is needed. Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
6. Sponsor Responsibilities
Sponsors must ensure timely submission and accurate data. If limited data is available (e.g., device not supplied elsewhere), this should be stated. Reports support proactive identification of safety or performance concerns. Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
7. Updates and Resources
Guidance published 21 June 2022, last updated 23 September 2024. Key resources include the annual report template (Excel file). Source: https://www.tga.gov.au/resources/guidance/submitting-annual-reports-medical-devices
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
TGA Guidance on Clinical Trial Safety Reporting: Significant Safety Issues and Urgent Safety Measures
The TGA provides guidance on roles and responsibilities for reporting significant safety issues (SSIs) and urgent safety measures (USMs) in clinical trials of unapproved therapeutic goods in Australia, aligning with NHMRC standards to ensure participant safety and trial integrity.
Approximately 5 minutes
TGA Laboratory Testing of Therapeutic Goods: Quality Assurance and Safety Monitoring
The TGA Laboratories perform risk-based testing on therapeutic goods, including medicines, medical devices, and biologicals, to verify compliance with quality standards, detect defects, and support regulatory actions for public health protection.